Your session is about to expire
← Back to Search
Corticosteroid
Bupivacaine/triamcinolone injection for Cough
Phase 3
Recruiting
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately pre-treatment and post-treatment at 2 weeks
Awards & highlights
Study Summary
This study is evaluating whether a specific injection may help reduce coughing in individuals with neurogenic cough.
Eligible Conditions
- Cough
- Caudal Epidural Block Therapy
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately pre-treatment and post-treatment at 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately pre-treatment and post-treatment at 2 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
2 week post-treatment cough severity index score improvement
2 week post-treatment cough-specific quality-of-life questionnaire score improvement
Secondary outcome measures
12 week post-treatment cough severity index score improvement
12 week post-treatment cough-specific quality-of-life questionnaire score improvement
6 week post-treatment cough severity index score improvement
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Bupivacaine/triamcinolone injectionExperimental Treatment1 Intervention
2-cc injection (mixture consisting of 1-cc of 0.5% Bupivacaine injection and 1cc of 40mg/cc triamcinolone acetonide suspension injection) will be delivered percutaneously into the region of the proximal superior laryngeal nerve, every 1-2 weeks, for total of 2 to 3 injections
Group II: Saline injectionPlacebo Group1 Intervention
2-cc injection of normal saline will be delivered percutaneously into the region of the proximal superior laryngeal nerve, every 1-2 weeks, for total of 2 to 3 injections
Find a Location
Who is running the clinical trial?
University of South FloridaLead Sponsor
414 Previous Clinical Trials
188,232 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger